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Obscurin Is Required for the Lateral
Alignment of Striated Myofibrils in Zebrafish
Maide Ö. Raeker,1 Fengyun Su,2 Sarah B. Geisler,1 Andrei B. Borisov,1
Aikaterini Kontrogianni-Konstantopoulos,3 Susan E. Lyons,2 and Mark W. Russell1
Obscurin/obscurin-MLCK is a giant sarcomere-associated protein with multiple isoforms whose
interactions with titin and small ankyrin-1 suggest that it has an important role in myofibril assembly,
structural support, and the sarcomeric alignment of the sarcoplasmic reticulum. In this study, we
characterized the zebrafish orthologue of obscurin and examined its role in striated myofibril assembly.
Zebrafish obscurin was expressed in the somites and central nervous system by 24 hours post-fertilization
(hpf) and in the heart by 48 hpf. Depletion of obscurin using two independent morpholino antisense
oligonucleotides resulted in diminished numbers and marked disarray of skeletal myofibrils, impaired
lateral alignment of adjacent myofibrils, disorganization of the sarcoplasmic reticulum, somite
segmentation defects, and abnormalities of cardiac structure and function. This is the first demonstration
that obscurin is required for vertebrate cardiac and skeletal muscle development. The diminished capacity
to generate and organize new myofibrils in response to obscurin depletion suggests that it may have a vital
role in the causation of or adaptation to cardiac and skeletal myopathies. Developmental Dynamics 235:
2018–2029, 2006. © 2006 Wiley-Liss, Inc.
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INTRODUCTION
Obscurin/obscurin-MLCK is a re-
cently identified giant protein that, in
adult mammals, is predominantly ex-
pressed in striated muscle (Young et
al., 2001; Bang et al., 2001; Russell et
al., 2002). Through alternative splic-
ing and at least two translation initi-
ation and termination sites, multiple
obscurin isoforms can be expressed
(Russell et al., 2002) (Fig. 1). The most
widely studied isoform, identified as
obscurin, was originally characterized
by Young et al. (2001) and encodes for
at least 67 tandemly arranged immu-
noglobulin domains as well as 2 fi-
bronectin, a calcium/calmodulin-bind-
ing, a Rho guanine nucleotide
exchange factor (GEF), and an
ankyrin binding (Kontrogianni-Kon-
stantopoulos et al., 2003; Bagnato et
al., 2003) domain(s). A second giant
isoform encodes for all of these do-
mains except for the ankyrin-binding
domain and instead has two tandemly
arranged carboxy terminal serine-
threonine kinase domains related to
myosin light chain kinase (MLCK)
(Russell et al., 2002). Obscurin-MLCK
appears to be the vertebrate ortho-
logue of Unc-89 (Sutter et al., 2004), a
732-kD sarcomeric protein that was
first characterized in Caenorhabditis
elegans (Benian et al., 1996). In nem-
atodes with a mutation of Unc-89, the
myosin thick filaments are highly dis-
organized and lack an M-band in most
mutant alleles (Waterston et al.,
1980), suggesting that Unc-89 is re-
quired for M-band assembly in inver-
tebrates. Like obscurin, Unc-89 has
multiple isoforms, some with MLCK-
like domains, which appear to have
vital and non-redundant roles in myo-
fibril assembly (Small et al., 2004).
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In vertebrates, much of the work to
date has focused on the functions of
the obscurin isoform. In mature myo-
cytes, this isoform localizes to both the
Z band, the lattice that supports the
actin thin filament array, and the M
band, the center of the myosin thick
filament assembly (Kontrogianni-
Konstantopoulos et al., 2003; Bagnato
et al., 2003; Borisov et al., 2003). Its
expression is increased in animals ex-
posed to aortic constriction and its cel-
lular localization is concentrated at
sites of new myofibril assembly
(Borisov et al., 2003). Based on these
studies and its similarity to Unc-89,
obscurin has been proposed to have an
important role in the assembly of new
myofibrils. Recently, this was sup-
ported using in vitro models of cardiac
(Borisov et al., 2004, 2006) and skele-
tal muscle (Kontrogianni-Konstanto-
poulos et al., 2004) myofibrillogenesis.
Inhibition of obscurin expression by
small interfering RNA expression
(Borisov et al., 2006) or overexpres-
sion of part of the COOH-terminus of
obscurin (Kontrogianni-Konstanto-
poulos et al., 2004) resulted in an in-
ability to incorporate myosin into the
myofibrillar array. Furthermore,
gradual cellular depletion of obscurin
was associated with the progressive
instability of previously assembled
myofibrils and an inability to advance
past the initial stages of new myofibril
assembly (Borisov et al., 2006).
While in vitro studies have sug-
gested that obscurin plays a vital role
in vertebrate striated muscle develop-
ment, the in vivo effects of gene loss
have not been examined. Therefore, in
this study, obscurin expression was
depleted in developing zebrafish em-
bryos using morpholino antisense in-
hibition. The zebrafish is an increas-
ingly utilized model in the study of
vertebrate cardiac and skeletal mus-
cle development due to the similari-
ties of these processes with those in
higher vertebrates and the accessibil-
ity of the developing embryo (Yelon,
2001; Costa et al., 2002). Morpholino
antisense inhibition of obscurin ex-
pression allowed the level of depletion
to be varied to reveal a range of devel-
opmental defects depending on the
level of inhibition. Increasing levels of
obscurin inhibition were associated
with progressive abnormalities of
myofibril assembly and somite archi-
tecture. Even low dose morpholino in-
jection resulted in decreased numbers
and impaired organization of mature
myofibrils, a disruption of somite
boundaries, and abnormalities of car-
diac structure and function. This
study is the first to demonstrate a re-
quirement for obscurin in normal ver-
tebrate striated muscle development
in vivo. Furthermore, the findings sup-
port an important role for obscurin in
patterning higher-order muscle struc-
ture and, in coordination with other cy-
toskeletal elements, in stabilizing cell-





In preparation for the morpholino
studies, BLAST sequence similarity
(tblastn) searches (http://www.ensembl.
org/Multi/blastview?speciesDanio_
rerio), using the human obscurin/ob-
scurin-MLCK amino acid sequence as
a probe, were performed to determine
the number and composition of the ze-
brafish orthologues of the obscurin/ob-
scurin-MLCK gene. Putative coding
sequences corresponding to obscurin/
obscurin-MLCK were identified and
localized to two different contiguous
genomic DNA sequences (GenBank
ID: CR792456 and GenBank IDs:
AL844185 and CR394562) using
BLAST similarity search (blastn). The
genomic sequences AL844185 and
CR394562 were determined to overlap
and represent a single contiguous
genomic sequence. The two genomic
contiguous sequences, CR792456 and
AL844185/CR394562, have been
mapped to zebrafish chromosomes 24
and 8, respectively (http://www.ensem-
bl.org/Danio_ rerio).
The genomic DNA sequences were
scanned for putative coding sequences
using GENSCAN and composite
cDNA sequences were assembled for
each. The protein predicted to be en-
coded by the chromosome 24 sequence
was similar in size and composition to
the obscurin isoform of obscurin/ob-
scurin-MLCK (Young et al., 2001) and
was, therefore, labeled the zebrafish
obscurin gene. Like mammalian ob-
scurin, it contains a conserved motif
(EETITTVVK) and more carboxy ter-
minal sequences that have been
shown to mediate binding to ankyrin
(Kontrogianni-Konstantopoulos et al.,
2003; Bagnato et al., 2003), indicating
that ankyrin binding is likely to be an
important and conserved function of
zebrafish obscurin (Fig. 1C).
The zebrafish orthologue of obscurin/
obscurin-MLCK, which mapped to chro-
mosome 8, is predicted to be similar in
size and composition to the giant iso-
form of obscurin-MLCK and has been
labeled obscurin-MLCK to distinguish
it from the zebrafish obscurin gene lo-
cus. Phylogenetic analysis of the Rho-
GEF domains of the zebrafish ob-
scurin and obscurin-MLCK genes
supports the assertion that these co-
orthologues duplicated and diverged
after evolution of the common ances-
tor shared with higher vertebrates
(Fig. 1B).
Expression of Obscurin and
Obscurin-MLCK in Zebrafish
Embryos
Reverse transcriptase primed PCR
(RT-PCR) was used to amplify a por-
tion of the 5 end of the zebrafish ob-
scurin gene from mRNA at multiple
stages of development. Expression of
obscurin in whole embryo mRNA
preparations was noted by 22 hr post-
fertilization (hpf). The level of expres-
sion appeared to steadily increase as
development proceeded, reaching a
peak at approximately 24–48 hpf,
with expression persisting into adult-
hood (Fig. 2A).
Obscurin mRNA expression was ob-
served diffusely throughout the em-
bryo at a low level by whole mount RNA
in situ hybridization using a probe from
the 5 end of the gene (data not shown).
A similar RNA expression pattern was
noted by Thisse et al. (2004) (direct sub-
mission to the ZFin database) with a
probe to the ankyrin binding domain at
the 3 end of the zebrafish obscurin
transcript (see immunostaining of Zfin




EST-041111-135). This pattern of RNA
expression is consistent with a strong
role of post-transcriptional regulation
in determining the tissue abundance of
obscurin. Therefore, antibodies recog-
nizing different obscurin and obscurin-
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Fig. 1. Obscurin/Obscurin-MLCK genes.
A: Diagramatic representation of the func-
tional domains of obscurin and obscurin-
MLCK. Functional domains include immuno-
globulin (Ig), fibronectin-3 (Fn), calcium/
calmodulin binding (CaM), RhoGEF (Rho),
and MLCK- (MLCK) like motifs. The epitopes
recognized by the link7, 4A8, Rho, Ank, and
SKII antibodies are indicated. In zebrafish, the
obscurin and obscurin-MLCK isoforms are
encoded by two different genes while in
mammals, they are alternatively spliced prod-
ucts of a single gene. In zebrafish, the smaller
obscurin-MLCK isoforms have not yet been
identified. B: Phylogenetic tree diagram pro-
duced by alignment of the RhoGEF domains
from the Unc-89 and obscurin-MLCK family
of genes. Included for reference is the corre-
sponding domain from the closely related hu-
man Trio protein. Amino acid sequences from
the Drosophila melanogaster (dm) and Cae-
norhabditis elegans (ce) Unc89 proteins and
from the zebrafish (dr), pufferfish (tn), chick
(gg), mouse (mm), and human (hs) obscurin
(Ob) and obscurin-MLCK (ObMLCK) proteins
were aligned using the Clustal-W method.
Note the close relationship of the correspond-
ing domains from the zebrafish and pufferfish
obscurin and obscurin-MLCK genes, sup-
porting duplication and divergence of the ob-
scurin-MLCK gene in ray finned fishes (boxed
in yellow). C: Alignment of the ankyrin binding
region from the human (hsOb) and zebrafish
(drOb) obscurin genes. Note the precise con-
servation of the putative core binding motif
(boxed in yellow).
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MLCK epitopes were used to examine
their tissue and cellular distribution
during development. Five antibodies
were used in these studies (see Fig. 1A):
Rho, a polyclonal antibody that recog-
nizes the RhoGEF domain of both the
obscurin and obscurin-gMLCK iso-
forms; SKII, a polyclonal antibody rec-
ognizing the amino MLCK domain of
obscurin-MLCK; link7, a polyclonal an-
tibody that recognizes epitopes in the
carboxy terminal kinase domain and,
therefore, detects all of the human ki-
nase-containing isoforms; Ank, a poly-
clonal antibody recognizing the ankyrin
binding domain of obscurin (Kontro-
gianni-Konstantopoulos et al., 2003);
and 4A8, a monoclonal antibody recog-
nizing an epitope in the amino terminus
of obscurin. All antibodies detect the
human, mouse, and rat orthologues of
obscurin and/or obscurin-MLCK (data
not shown). Using whole mount anti-
body in situ hybridization, each anti-
body demonstrated nearly identical tis-
sue distribution patterns during
development (Fig. 2B and data not
shown). Immunostaining for both ob-
scurin (Rho, Ank, and 4A8 antibodies)
and obscurin-MLCK (Rho, SKII, and
Link7) was noted in the central nervous
system and developing somites by 24
hpf. By 48 hpf, expression could also be
detected in the heart tube.
The immunolocalization patterns
also demonstrated similar but distinct
cellular distribution patterns of ob-
scurin and obscurin-MLCK during de-
velopment. At the onset of myofibril-
logenesis, both localized diffusely
along newly assembled myofibrils
with some organization overlying the
Z and M bands (Fig. 3A–D). In more
mature myofibrils at 72 hpf, obscurin
became more concentrated at the M
band (Fig. 3E,F) and obscurin-MLCK
at the Z band (Fig. 3G,H). This pat-
tern of sarcomeric localization of ob-
scurin during striated muscle differ-
entiation in zebrafish is consistent
with that previously noted in chick
cardiac explants (Young et al., 2001),
in remodeling rat cardiac myocytes in
primary culture (Borisov et al., 2003,
2004) and differentiating C2C12 myo-
blasts (Kontrogianni-Konstantopoulos
et al., 2006). This is the first localiza-
tion of the vertebrate obscurin-MLCK
isoforms during development and is
consistent with that noted in rat car-
diac myocytes (Russell et al.; unpub-
lished data).
Effect of Obscurin Inhibition
on Striated Muscle
Development
The patterns of tissue expression and
cellular distribution during develop-
ment suggest that both zebrafish ob-
scurin and obscurin-MLCK have cen-
tral roles in vertebrate cardiac and
skeletal muscle development. Given
the proposed direct involvement of the
COOH-terminus of obscurin in myofi-
bril assembly, this isoform was specif-
ically targeted for depletion using
antisense morpholino injections. Anti-
sense morpholinos directed at the 5
untranslated region (MO2) and tran-
scription start site (MO1) of the ze-
brafish obscurin gene were designed
and injected into zebrafish embryos at
the 1–4 cell stage. Immunostaining
with antibody recognizing the ob-
scurin RhoGEF domain (Rho) demon-
strated a reduction in obscurin ex-
pression (Fig. 4C). The level of
inhibition appeared to be dose depen-
dent with more severely affected em-
bryos demonstrating less obscurin im-
munostaining than more mildly
affected ones using identical reaction
conditions (data not shown).
Both morpholinos resulted in very
similar phenotypic effects (Fig. 4B).
Increasing antisense morpholino dos-
ages were associated with a progres-
sive compromise of striated muscle
development, increased curvature
and/or growth failure of the tail, in-
creased disruption of the somite
boundaries, and more severe cardiac
hypoplasia (Fig. 4A,B, and data not
shown). At a dose of 6 ng of MO2 and
12 ng of MO1, 84 and 85% of injected
embryos, respectively, demonstrated
irregular somite boundaries and a de-
creased number of skeletal myofibrils
while approximately 54 and 44%, re-
spectively, also demonstrated cardiac
hypoplasia and pericardia edema. In-
jection of 3 ng of MO2 was associated
with a similar incidence of cardiac and
skeletal muscle abnormalities, 55 and
85%, respectively, but diminished se-
verity, including better formed somite
boundaries, an increased number of
skeletal myofibrils, and less growth
impairment relative to the 6-ng dose.
Embryo mortality at 72 hpf was 5%
for the dosages of MO1 used in this
study (6 and 12 ng) and was 0, 2, and
12% at dosages of 3, 6, and 12 ng of
MO2, respectively. Injection of MOs
containing 5 base pair mismatches to
MO1 (CMO1: 12 ng) or MO2 (CMO2: 6
ng) did not result in any morphologi-
cal defects (Fig. 4B). Due to the spe-
cific, consistent abnormalities of stri-
ated muscle development and low
incidence of embryo mortality ob-
served with the injection of 3 or 6 ng of
MO2, these dosages of MO2 were used
in all subsequent studies.
Embryos injected with 3–6 ng of
MO2 responded vigorously to initial
stimulation although at rest they
were somewhat less active than the
control injected embryos at all time-
points. Morphant embryos examined
at 72 hpf displayed fewer muscle fi-
bers per somite and those myofibrils
that did form were disparate and dis-
organized compared to those in con-
trol-injected embryos (Fig. 5A.1,A.2).
In many instances, elongated, irregu-
lar myofibrils extended beyond the
somite boundary, often spanning the
length of two somites (Figs. 5A.2, 6).
These structures were not noted in
any of the control-injected embryos
(N12) but were noted in all embryos
injected with 3 ng (N12) or 6 ng
(N12) of MO2 that were examined
by immunohistochemical or electron
microscopic (EM) analysis. In all mor-
phant embryos, Z band architecture of
the individual sarcomeres was intact
with normal patterns of -actinin
staining and Z band spacing, despite
Fig. 2. Expression of obscurin and obscurin-
MLCK in developing zebrafish embryos. A: RT-
PCR of total RNA from zebrafish embryos using
primers from the 5 end of the obscurin/ob-
scurin-MLCK gene. RNA samples were pre-
pared from whole embryos 15, 22, 24, 36, 48,
60, and 72 hr post-fertilization (hpf) and from
adult zebrafish hearts. Expression is first noted
in embryos approximately 22 hpf with expres-
sion persisting in the adult heart. B: Immunolo-
calization of obscurin/obscurin-MLCK expres-
sion using the link7 and Ank antibodies in
zebrafish embryos at 48 hpf. Note the expres-
sion of obscurin and obscurin-MLCK in the
heart ( ∧ ) and skeletal muscle (arrows and inset,
far right). Immunolocalization of myosin (MF20
antibody), which decorates the A bands of stri-
ated muscle, is shown for comparison. Note
that, unlike myosin, both obscurin and ob-
scurin-MLCK are also expressed in non-muscle
tissues, including the central nervous system
(*), at this stage in development.
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the abnormal myofibril morphology
(Fig. 5A.2).
Thick filament organization, how-
ever, was not as well preserved (Fig.
5A.4,A.6,B.3). While many myofibrils
in the morphant embryos continued to
demonstrate a Z and M band localiza-
tion, in general, there was diminished
M band localization of obscurin (Fig.
Fig. 3.
Fig. 4.
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5A.6,A.8) particularly at the 6-ng
dose. M bands were noted to be con-
sistently present by electron micros-
copy (EM) at the 3-ng dosage (Fig.
5B.2) of MO2 and present in the vast
majority of myofibrils even at the 6-ng
dosage. However, each embryo in-
jected with 6 ng of MO2 and examined
by EM (6 embryos) displayed occa-
sional abnormalities of thick filament
organization, including irregularity of
the A/I junction, non-parallel thick fil-
ament alignment, and the loss of well-
formed M bands (Fig. 5B.3). Both the
regional variation in the degree of
myofibril organization and obscurin M
band localization may be due to re-
gional differences in morpholino con-
centration and, therefore, in degree of
obscurin depletion.
The most dramatic effects of mild
obscurin depletion (3 ng dose of MO2)
occurred not at the level of the sarco-
mere but at the integration of striated
myofibrils into larger functional units.
Specifically, lateral myofibril align-
ment was impaired in all MO2-in-
jected embryos with the frequency of
misaligned adjacent myofibrils in-
creasing with increasing morpholino
dose (Fig. 5C,D). In response to 3- or
6-ng MO2 injection, there was noted
to be more variable spacing between
adjacent myofibrils with an inability
to laterally align across the sarco-
plasm. These irregularities of lateral
alignment were associated with ap-
parent disorganization of the sarco-
plasmic reticulum and disruption of
many of the triads, the organized ar-
rangement of T-tubules and junc-
tional SR around the Z bands in the
embryonic skeletal muscle, due to
myofibril misalignment.
Effect of Obscurin Inhibition
on Somite Development
One of the more striking effects of ob-
scurin depletion was the dose-depen-
dant disruption of somite boundaries.
In zebrafish, somites are separated
from each other by the transverse my-
osepta and divided into ventral and
dorsal compartments by the horizon-
tal myoseptum (Holley and Nusslein-
Volhard, 2000). The myosepta are fi-
brous sheaths that are analogous in
structure and function to tendons in
that they transmit the force of muscu-
lar contractions from skeletal muscle
to the bony skeleton to enable move-
ment and locomotion (Holley and Nus-
slein-Volhard, 2000). In all (N24) 3-
and 6-ng MO2-injected embryos ex-
amined by immunostaining or EM,
there was noted to be a global disrup-
tion of somite segmentation. Trans-
verse myoseptae were irregular and
incomplete and only rarely could rem-
nants of the horizontal myoseptum be
identified. In response to obscurin de-
pletion, elongated myocytes extended
past where somite boundaries should
have been. Aberrant terminations of
myofibrils were noted mid-somite and
there was a marked variability in
myofibril length with the majority of
myofibrils being longer than expected
(Fig. 6A.2). These findings suggest
that obscurin is a fundamental compo-
nent of myoseptal formation, poten-
tially facilitating the organization and
anchorage of myofibrils to the extra-
cellular matrix.
Effect of Obscurin Inhibition
on Cardiac Development
The incidence and severity of the car-
diac abnormalities was directly corre-
lated with the morpholino dose in the
MO1- and MO2-injected embryos. At
the 3-ng dose of MO2, there was mild
pericardial edema and mild ventricu-
lar hypoplasia in 54% of the embryos
examined at 72 hpf. At the 6-ng dose
of MO2, morphant embryos examined
at 72 hpf demonstrated more marked
pericardial edema and more severe
ventricular hypoplasia than was ob-
served at the 3-ng dose. Irrespective of
the occurrence or absence of overt
pericardial edema, embryos injected
with 6 ng of MO2 had a slower aver-
age heart rate than controls [104  4
beats per minute (bpm) vs. 126  2
bpm; t-test, P  0.01]. As with the
skeletal myofibrils, cardiac myofibrils
in morphant embryos demonstrated
impaired alignment (3 and 6 ng MO2)
and thick filament abnormalities (6 ng
MO2) (e.g., “ragged” appearance of the




Identification of two zebrafish co-or-
thologues of the mammalian ob-
scurin/obscurin-MLCK gene was not
unexpected given the proposed ge-
nome duplication event that oc-
curred in teleost fish after evolution
of their common ancestor with
higher vertebrates (Amores et al.,
1998). After duplication, there is of-
ten divergent evolution of the two
zebrafish co-orthologues such that
they acquire unique functions or dif-
fering patterns of expression
(Postlethwait et al., 2004). This ap-
pears to be the case for the zebrafish
obscurin and obscurin-MLCK genes.
In higher vertebrates and in C. el-
Fig. 3. Cellular distribution of obscurin and obscurin-MLCK in zebrafish skeletal muscle during devel-
opment. Embryos were fixed at 24 (A–D), and 72 (E–H) hpf and co-immunolabeled with antibodies to
the ankyrin binding domain of obscurin (Ank) (red: A,B,E,F) or the carboxy terminal kinase domain of
obscurin-MLCK (link7) (red: C,D,G,H) and -actinin (green: B,D,F,H). At 24 hpf, while most of the cellular
obscurin and obscurin-MLCK remains diffusely localized, some begins to organize around the Z
(A–D:) and M bands (A–D:) of the maturing myofibrils. It is important to note that all myofibrils with
a striated pattern of -actinin staining also demonstrate organization of some of the obscurin and
obscurin-MLCK around the M and Z bands. Later in development, by 72 hpf, both obscurin and
obscurin-MLCK demonstrate a more distinct striated pattern with obscurin more concentrated at the M
bands (E–H:) and obscurin-MLCK at the Z bands (E–H:). Similar results were obtained using
antibodies to the amino terminal immunoglobulin domains of obscurin (4A8) and the internal kinase
domain of obscurin-MLCK (SKII). Scale bars  20 (A–D) and 10 (E–H) m.
Fig. 4. Suppression of obscurin expression in MO2-treated embryos. A: Embryos injected with
MO2 (MO2; 3 and 6 ng) or a control morpholino (CMO2; 6 ng) were examined at 72 hpf. Note that
the morphant embryos are slightly shorter with diminished regularity and definition of the transverse
myoseptae () and moderate pericardial edema (). Most 72-hpf MO2-treated embryos demon-
strated a looped but hypoplastic heart with a small, underdeveloped ventricular (v) chamber
compared to control. B: Phenotypic effects of injection with MO1, MO2, or the corresponding
control morpholinos, CMO1 and CMO2. Embryos were phenotyped at 72 hpf and categorized as
having cardiac and/or somite defects. All embryos injected with control morpholinos at these
dosages were morphologically normal. C: Suppression of obscurin expression in MO2-injected
embryos (6-ng dose). MO2-injected 72-hpf embryos demonstrate reduced immunostaining for
obscurin (Rho Ab) compared to controls using identical reaction conditions.




Fig. 5. Obscurin depletion is associated with
abnormalities of thick filament assembly and
myofibril alignment in zebrafish embryos. At 72
hpf, embryos that had been injected with con-
trol (CMO2) or obscurin morpholino (MO2) were
evaluated by immunohistochemical (A) and
electron microscopic analysis (B). A: Control
[CMO2 (6 ng); A.1,3,5] and obscurin morphant
[MO2 (3 ng); A.2, (6 ng) A.4,6] embryos were
hybridized with antibodies to -actinin (A.1–
2,5–6), and/or obscurin (Ank; A.3–6). A.5 and
A.6 correspond to A.3 and A.4. Note that there
irregularities of myofibril alignment and orienta-
tion in the skeletal muscle of the morphant em-
bryos. The morphant embryos demonstrate a
normal Z band structure and spacing as dem-
onstrated by -actinin localization, but there is
decreased relative accumulation of obscurin at
the M band () as opposed to the Z band ()
(compare A.4 and A.6 to A.3 and A.5). Scale
bars  20 m. B: Electron micrographs of skel-
etal muscle from control [CMO2 (6 ng); B.1] and
obscurin morphant [3 ng (B.2) and 6 ng (B.3) of
MO2] embryos. Note the irregular spacing and
misalignment of adjacent myofibrils in the mor-
phant embryos. The Z bands () of adjacent
myofibrils do not align and the sarcoplasmic
reticulum (*) appears disorganized, often lack-
ing the well-ordered triads ( ∧ ) evident in the
control embryos. At the higher morpholino
dose, there was occasional disorganization of
the thick filaments () with irregularity of the M
bands (). C: Myofibril misalignment in control
and morphant embryos. The percentage of
myofibrils that were not aligned in register with
the adjacent myofibril within the same myocyte
was significantly greater in morphant than con-
trol embryos (*t-test; P  0.01) and increased
with increasing morpholino dose. D: Areas of
myofibril disarray were clustered with some ar-
eas demonstrating high rates of misalignment.
Note the staircase appearance of the Z bands
() in the skeletal muscle of this 72-hpf embryo
injected with 6 ng of MO2.
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egans, isoforms of obscurin-MLCK
and Unc-89 either containing or
lacking kinase domains are gener-
ated from a single gene (Russell
et al., 2002; Small et al., 2004). In
zebrafish, the two co-orthologues of
obscurin/obscurin-MLCK have evolved
such that one expresses only tran-
scripts lacking the kinase and con-
taining an ankyrin binding motif
while the other expresses the kinase
domains without the ankyrin binding
motif.
The predicted composition of both
zebrafish obscurin and obscurin-
MLCK is highly similar to mamma-
lian obscurin/obscurin-MLCK (Young
et al., 2001; Russell et al., 2002) and all
of the identified signaling domains and
protein interaction sites appear to be
conserved in one or both of the zebrafish
genes. Furthermore, the zebrafish ob-
scurin and obscurin-MLCK proteins ac-
cumulate in a spatially and temporally
restricted pattern in the developing em-
bryo that is highly similar to that noted
for obscurin/obscurin-MLCK in the ro-
dent (unpublished observations). These
similarities between the zebrafish and
mammalian obscurin genes strongly
support the use of the zebrafish as a
model to examine the roles of obscurin
during vertebrate development.
Morphant Phenotype
To examine the role of obscurin in
myofibrillogenesis during develop-
ment, morpholino antisense nucleo-
tides were used to diminish obscurin
expression in zebrafish embryos. One
of the limitations of using morpholino
constructs to examine gene function is
differentiating the potential non-spe-
cific toxic effects of the morpholino in-
jection from the specific effects of the
“knock-down” of target gene expres-
sion. This is usually accomplished by
demonstrating that the injection of
two independent morpholinos causes
a similar phenotype that is not appar-
ent in embryos injected with mis-
match control morpholinos. Added as-
surance that the phenotype is specific
can be accomplished by demonstrat-
ing that the morphant phenotype
mimics that of a zebrafish line harbor-
ing a mutation of the gene being stud-
ied or can be rescued by reintroduc-
Fig. 6. Obscurin depletion disrupts somite ar-
chitecture. A: Embryos injected with MO2 (6 ng;
A.2) or a control morpholino CMO2 (6 ng; A.1)
were fixed and immunostained for -actinin at
72 hpf. Note that in the morphant embryos,
there are no detectable horizontal myoseptae
() and only rudimentary transverse myoseptae
( ∧ ) compared to control embryos. Elongated,
disarrayed myofibrils often extend beyond the
length of a normal somite. B–D: Electron micro-
graphs of transverse myoseptae from control [6
ng CMO2 (B)] and obscurin morphant [3 ng (C)
and 6 ng (D) of MO2] embryos. Morphant em-
bryos displayed rudimentary transverse myo-
septae (C:*, C,D: ) at the ends of the skeletal
myocytes compared to the well-organized
transverse myoseptae of control embryos (B: *).
Fig. 7. Cardiac abnormalities in morpholino-treated embryos. A–C: Morphant embryos demonstrated a spectrum of cardiac defects that ranged from
mild (B) to severe (C) ventricular (v) hypoplasia. The most severely affected embryos (6 ng of MO2) studied had tube-like hearts (C). A control 72-hpf
embryo is shown for comparison (A). All cardiac defects were associated with mild to marked pericardial edema. D: The heart rate of the morphant
embryos (6 ng of MO2) was significantly less than that of the control embryos (*t-test; P  0.01). As with skeletal muscle, cardiac myofibrils in morphant
embryos [3 ng (F) and 6 ng (G) of MO2] were poorly aligned and organized compared to those in control-injected embryos (E). Some M bands () are
apparent in morphant embryos but are much more irregular than in control embryos.
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tion of the knocked-down protein. In
this study, the morphant phenotype
was the same for two independent
morpholinos and was not noted in con-
trol-injected embryos. However, no
mutations of the obscurin gene have
been identified in zebrafish and ob-
scurin is too large to express using
current approaches. Therefore, vali-
dation of the observed morphant phe-
notype must rely on the consistency of
the observations with the previously
described in vitro models of obscurin
function and with the absence of sim-
ilar findings in response to non-spe-
cific toxic effects of morpholino injec-
tion. In previous studies, a number of
toxic effects of morpholinos have been
reported (reviewed in Heasman,
2002). These include widespread cell
death (Braat et al., 2001; Lele et al.,
2001), neural degeneration (Nasevi-
cius and Ekker, 2000; Karlen and Re-
bagliati, 2001), and defects in epiboly
(Imai and Talbot, 2001). While these
non-specific reactions can affect the
development of the notochord result-
ing in severely misshapen embryos
with agenesis or hypoplasia of distal
somites, in no instance have defects in
somite organization or sarcomere
structure been noted. The appearance
of these abnormalities even in em-
bryos with relatively mild phenotypic
abnormalities (see Fig. 4A.2) suggests
that they are specific for the effects of
obscurin depletion and do not repre-
sent non-specific morpholino toxicity.
Furthermore, the findings in this
study support and extend those of
prior in vitro models of obscurin func-
tion as described below.
Obscurin’s Role in Myofibril
Assembly and Alignment
Previous studies have proposed that
obscurin has important functions in
the new myofibril assembly and align-
ment (Borisov et al., 2003, 2006; Kon-
trogianni-Konstantopoulos et al.,
2004, 2006). The morphant phenotype
observed in the injected embryos sup-
ports and extends those assertions.
The reduction in the number and or-
ganization of skeletal myofibrils in re-
sponse to obscurin treatment indi-
cates that obscurin is required for the
assembly of new myofibrils in vivo
during development. All myofibrils
that did form in the morphant em-
bryos contained obscurin suggesting
that obscurin is absolutely required
for myofibril assembly. That the
amount of obscurin per myofibril was
not dramatically different in the mor-
phant and control embryos suggests
that there may be a minimum number
of obscurin molecules required to as-
semble each sarcomere and that, un-
der normal conditions, obscurin con-
centration is fairly close to this lower
limit. Given the potential energetic
cost of producing such a large protein,
this is not surprising and is consistent
with the observation that obscurin de-
pletion resulted in a reduction in the
number of myofibrils rather than a
dramatic reduction in the amount of
obscurin per myofibril.
However, even a mild reduction in
the amount of obscurin per myofibril
was sufficient to produce morphologic
abnormalities of myofibril structure.
Myofibrils that did form were variable
in length, often extending past the
projected somite boundary, and were
not correctly aligned relative to each
other. This is consistent with our in
vitro studies in which cardiac myo-
cytes completely depleted of obscurin
using RNAi-mediated inhibition were
unable to generate new myofibrils and
those that did form in the presence of
limited obscurin displayed marked ab-
normalities of morphology and align-
ment (Borisov et al., 2006). Taken to-
gether, these studies identify an
important scaffolding function of ob-
scurin in the myofibril assembly and
alignment process both in vivo and in
vitro.
The lateral alignment of adjacent
myofibrils is recognized as a critical
step in the organization of the sarco-
plasmic reticulum, in the structural
fixation of the myofibrils, and the sub-
sequent coordinated and efficient
transfer of contractile force to the ex-
tracellular matrix (reviewed in Bloch
et al., 2002). However, the mecha-
nisms directing this alignment have
been poorly understood. It was origi-
nally thought that desmin and the in-
termediate filament system might
have an important role. While desmin
has been demonstrated to participate
in the structural support of the myofi-
bril and the maintenance of lateral
alignment, mice lacking desmin did
not demonstrate widespread abnor-
malities of myofibril assembly or
alignment during development (Mil-
ner et al., 1996) suggesting that other
structural proteins might initiate the
alignment process. This study and our
previous work (Borisov et al., 2004,
2006) indicates that obscurin is a crit-
ical initial regulator of the lateral
alignment and organization of the
myofibril, a process that is central to
efficient striated muscle function.
There are apparent similarities be-
tween the somite and skeletal muscle
defects noted in the obscurin mor-
phant embryos in this study and those
noted when the expression of the skel-
etal muscle isoform of titin was inhib-
ited by antisense morpholinos. Al-
though a detailed phenotype of the
skeletal muscle titin morphant em-
bryos was not presented, it is interest-
ing that they were also noted to have
defects in somite architecture (Xu et
al., 2002). Therefore, titin and ob-
scurin may coordinately organize not
only the sarcomere and the myofibril
but higher-order muscle structures as
well, in this case the myotome of the
somite. Whether or not other sarco-
meric proteins also participate in the
organization of the somite is not yet
known.
The defects of somite patterning
noted in the obscurin morphant em-
bryos are similar to those previously
noted in zebrafish embryos depleted of
periostin, an extracellular matrix pro-
tein proposed to have a role in the
establishment of myotendinous junc-
tions (Kudo et al., 2004). The divisions
between somites are composed of a
sheet of extracellular matrix that in-
cludes periostin and other connective
tissue proteins such as laminin, fi-
bronectin, tenascin C, and type I col-
lagen (Parsons et al., 2002). This con-
nective tissue appears to form as
discontinuous islands of extracellular
matrix that coalesce to form a nearly
continuous sheath (Henry et al., 2000;
Crawford et al., 2003). In zebrafish, a
single myocyte spans the length of the
somite from one myosepta to the next.
In zebrafish depleted of periostin us-
ing antisense morpholinos, there was
disruption of the myosepta due to
variable myofibril length with some
myofibrils extending past the pro-
jected somite boundary. Furthermore,
the number of myofibrils was dimin-
ished and the myofibrils that re-
mained were disorganized and varied
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in width (Kudo et al., 2004). This is
remarkably similar to the abnormali-
ties noted in the obscurin morphant
embryos and suggests an indirect co-
ordination between periostin and ob-
scurin in organizing myofibrillar
structure and anchoring the myofibril
to the extracellular matrix.
The link between obscurin, an intra-
cellular cytoskeletal protein, and com-
ponents of the extracellular matrix may
involve focal adhesion complexes that
have been postulated to mediate somite
boundary formation (Henry et al., 2001;
Crawford et al., 2003). The invertebrate
orthologue of obscurin, Unc-89, has
been demonstrated to participate in the
formation of integrin adhesion com-
plexes, mediating the organization and
attachment of myofilaments to these
complexes at the M band through its
interaction with actopaxin (Lin et al.,
2003). Recently, it has been demon-
strated that organization of fibronectin
within the somite boundary by integrin
alpha5 is required for proper epithelial-
ization and boundary maintenance
(Koshida et al., 2005). It is possible,
therefore, that like its invertebrate or-
thologue, Unc-89, obscurin participates
in the linkage of myofibrils to the extra-
cellular matrix through integrin adhe-
sion complexes and that disruption of
this linkage affects the stability and or-
ganization of the somite boundaries and
myofibril architecture.
Parallels to Human Disease
These studies indicate a critical role of
obscurin in new myofibril assembly and
alignment in vivo. The parallels be-
tween the obscurin and skeletal muscle-
specific titin morphant embryos sup-
port a coordinate function of these two
giant proteins in the scaffolding and or-
ganization of new myofibrils and the es-
tablishment of higher-order muscle
structures. Titin and other proteins
with similarly critical roles in the as-
sembly and structural support of stri-
ated myofibrils including actin, myosin,
-actinin, and desmin, have been in-
variably determined to be responsible
for the causation of cardiac and/or skel-
etal myopathies (Morita et al., 2005).
Indeed, the phenotype of the obscurin
morphant embryos recapitulates many
of the features of myopathic disorders in
that, in response to obscurin depletion,
there is a marked reduction in the num-
ber and organization of muscle fibers.
Given the findings of this study and
previous studies, we would anticipate
that human mutations of obscurin
would also result in a myopathic phe-
notype. To date, no mutations in the
human obscurin gene have been iden-
tified. However, multiple myopathies
have been mapped to the region on
human chromosome 1 (1q42) that en-
codes for obscurin. While some of
these disorders have been determined
to be secondary to mutations of car-
diac actin, -actinin, or the cardiac ry-
anodine receptor, all of which map to
this “cardiac-rich” region, the genetic
cause of at least one 1q42-mapped my-
opathy, congenital muscular dystro-
phy type 1B, has not yet been charac-
terized (Brockington et al., 2000).
Given the phenotype of the obscurin
morphant embryos in this study, we
would anticipate that thorough
screening of individuals and families
with cardiac or skeletal myopathies






Zebrafish were maintained and bred
and zebrafish embryos were staged as
previously described (Westerfield,
1995). Collected embryos were main-
tained in egg water (0.006% Instant
Ocean in distilled water) with 2 parts
per million methylene blue at 28.5°C.
Embryo age was defined as hours post
fertilization (hpf). Experiments were
performed using the wild-type EK
strain. Embryo medium was supple-
mented with 0.003% 1-phenyl-2-thio-
urea (Sigma, St. Louis, MO) at 24 hpf
to prevent pigment formation. Em-
bryos less than 72 hpf were dechorion-
ated with 2 mg/ml pronase in phos-
phate-buffered saline (PBS).
Partial Cloning of the
Zebrafish Obscurin and
Obscurin-MLCK genes
Cloning of the obscurin-MLCK kinase
and Rho guanine nucleotide exchange
factor domains were reported previ-
ously (Sutter et al., 2004). Additional
coding sequence was derived using
GENSCAN analysis (http://genes.mit.
edu/GENSCAN.html) of the zebrafish
genomic DNA sequence to generate
PCR primers that were used to amplify
the cDNA sequence from adult ze-
brafish RNA as was described for the
cloning of the human obscurin-MLCK
(Russell et al., 2002). A partial sequence
has been deposited in GenBank (acces-
sion number: NM_001003849). The
remainder of the proposed zebrafish
obscurin-MLCK sequence was deter-
mined using BLASTN (http://
www.ncbi.nlm.nih.gov/BLAST) se-
quence similarity search to construct
the genomic DNA sequence encompass-
ing the zebrafish obscurin-MLCK gene.
This sequence was searched for puta-
tive coding regions using GENSCAN.
During the characterization of the
zebrafish obscurin-MLCK gene, a sec-
ond co-orthologue of obscurin/ob-
scurin-MLCK was identified. The
translation initiation codon for the ze-
brafish obscurin gene was identified
by BLAST algorithm (tblastn) se-
quence homology search of the ze-
brafish EST database using the corre-
sponding human obscurin amino acid
sequence as a probe. The identified
zebrafish EST sequences were used to
identify the corresponding genomic
DNA sequence by BLAST homology
search as described above. This
genomic DNA sequence was searched
for potential coding regions using
GENSCAN and a composite obscurin
coding sequence constructed.
Phylogenetic Analysis
Amino acid sequences of the RhoGEF
domains from the zebrafish (AY603753.1:
AA 1-280), pufferfish (CAG08043: AA
4051-4450), chicken (XP_418501: AA
8428-8800), mouse (BC060226.1: AA
744-1811), and human obscurin-
MLCK (CAI19285: AA 5697-6008);
the zebrafish (AAH91815: AA 214-
520) and pufferfish (CAF98444: AA
1891-2260) obscurin; and the C. el-
egans (NP_001020984: AA 153-500)
and D. melanogaster (DQ431841: AA
1-280) Unc-89 proteins, were aligned
using the Clustal-W alignment algo-
rithm of the DNASTAR program
(DNASTAR Inc., Madison, WI). The
corresponding domain from the hu-
man Trio (AAH60724: AA 826-1200)
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Obscurin morpholino antisense oli-
gonucleotides targeting the transla-
tion initiation site (MO1) and 5UTR
(MO2) or a control morpholino (5
base pair mismatch to MO1 or MO2)
were designed by GENE TOOLS,
LLC (Philomath, OR). Sequences
were as follows: Obscurin antisense
MO1, 5-CCGCCAAATAGATTCT-
GATCCAT-3; Control MO1, 5-CT-
gCGgCAAATAcATTCTcATCgAT-3;




ters indicate base changes from the
antisense oligos). MOs were dis-
solved to a stock concentration of 4
mM in 30% Danieau Solution, and
diluted to 1.5, 3, or 6 ng/nl. Two mi-
croliters of diluted morpholino was
injected into 1– 4-cell-stage embryos
using a pneumatic picopump (World
Precision Instruments).
RNA Isolation and RT-PCR
To determine the onset of obscurin-
MLCK expression, total RNA was iso-
lated from uninjected embryos at 15,
22, 24, 36, 48, 60, and 72 hpf stages
using SV Total RNA Isolation System
(Promega, Madison, WI). RNA concen-
tration and purity was determined by
optical density reading at 260 nm and
the ratio of 260/280 nm absorbance,
respectively. A total of 0.6 g RNA
was used in a 25-l reaction volume to
synthesize cDNA using Access RT-
PCR kit (Promega Inc.). A fragment of
5UTR region of zebrafish obscurin
cDNA was amplified by PCR (forward
primer, 5-CAGTTCGCGGAATTTAC-
CTG; reverse primer, 5-TGCTTTC-
TTTCCTCCCTCAA). As a control, the






A 580-bp cDNA encoding for most of
the terminal kinase domain of human
obscurin-MLCK was cloned into the
pRSET (Invitrogen Corp., Carlsbad,
CA) expression vector and the protein
expressed in the E. coli strain
BL21(DE3)pLysS. Induction of ex-
pression was carried out at 37°C using
0.1 M isopropyl-B-D-thiogalactopyr-
anoside (IPTG). Cells were harvested
5 hr after induction of expression. Ex-
pressed protein was purified and dia-
lysed according to Xpress system pro-
tein purification protocol (Invitrogen
Inc.). The protein was isolated under
denaturing conditions and purified us-
ing ProBond resin (Invitrogen Inc.).
The eluted protein was dialyzed
against 10 mM tris, pH 8.0, 0.1% Tri-
ton-X-100 overnight at 4°C to remove
urea. The purified protein was sup-
plied to Bethyl Laboratories (Mont-
gomery, TX) for production of poly-
clonal rabbit antisera. Antibody
purification was performed with pro-
tein A column (Pierce Inc.) following
the manufacturer’s instructions.
Obscurin-Rho antibody.
The Rho antibody was prepared by in-
serting a 780-bp cDNA fragment en-
compassing the RhoGEF domain of the
human obscurin-MLCK gene into pR-
SET vector. Polyclonal antiserum was
produced in rabbits using Tris-HCl gel
purified protein (Harlan Bioproducts
for Science Inc., Indiannapolis, IN). To
affinity purify the Rho antibody, bacte-
rial lysates expressing Rho were loaded
onto a Tris-HCl gel and transferred to
nitrocellulose. Ponceau stain was used
to visualize the Rho band, which was
cut out and washed. Poorly bound pro-
tein was removed with 100 mM glycine,
pH 2.5. The nitrocellulose strip was
washed and blocked with 3% bovine se-
rum albumin. Rho polyclonal antiserum
was incubated with the strip overnight,
and bound antibody was eluted with
glycine.
Characterization of the Ank and
4A8 antibodies was described previ-
ously by Kontrogianni-Konstantopou-
los et al. (2003, 2004), respectively.
Wholemount Immunostaining
Embryos were fixed for 6 hr with 4%
paraformaldehyde. Single labeling
was carried out using Vectastain ABC
Elite kit (Vector Laboratories, Burlin-
game, CA) and the staining was re-
vealed with DAB. The following dilu-
tions were used for single staining.
MF20 (Developmental Hybridoma
Bank, University of Iowa) 1:1, ob-
scurin-Rho 1:2, link7 1:10. Leica MZ-
FLIII dissecting microscope and Nikon
microphot-SA compound microscope
were used to visualize embryos. For
dual labeling, -actinin (Sigma Inc.)
(dilution 1:20) in combination with a
polyclonal antibody (obscurin-Rho,
1:2; link7, 1:3; obscurin-Ank, 1:10)
were used. FITC-conjugated goat anti-
mouse IgG and Texas Red-conjugated
Goat Anti-Rabbit IgG (Jackson Immu-
noResearch Laboratories) were di-
luted to 1:100 to reveal staining. For
the MF20 antibody, TRITC-conju-
gated goat anti-mouse IgG (1:100) was
used as a secondary antibody. Em-
bryos were mounted onto slides using
ProLong Gold Antifade Reagent (Mo-
lecular Probes) and visualized on an
Olympus FV-500 confocal microscope.
Electron Microscopy
Embryos at 72 hpf were fixed with
2.5% glutaraldehyde and 2.0% para-
formaldehyde in 0.1M Sorenson’s
buffer for overnight. The embryos
were rinsed twice for 15 min in the
buffer and post fixed for 1 hr in 1%
osmium tetroxide in the same buffer.
After two 10-min washes with
ddiH2O, they were stained en bloc
with saturated uranyl acetate for 30
min. They were then dehydrated with
a graded series of ethanol, cleared
with propylene oxide, and embedded
in Epon 812. Ultra-thin sections were
cut on Ultracut E ultramicrotome
(Reichert-Jung, Vienna, Austria) and
stained with saturated uranyl acetate
and lead citrate. The sections were ex-
amined with a Philips CM100 trans-
mission electron microscope, at an ac-
celerating voltage of 60 kV. Frequency
of myofibril misalignment was scored
based on EM images from CMO2-
(6-ng injection; N3) and MO2-in-
jected (3- and 6-ng injections; N2
each) embryos. A minimum of 30 ad-
jacent myofibrils were scored for each.
Adjacent myofibrils within a given
skeletal myocyte from a mid-tail
somite were determined to be mis-
aligned if the corresponding M and Z
bands did not align correctly and the T
tubules were not intact.
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